Zenas BioPharma, Inc. Common Stock Cash Flow Reinvestment Rate
Zenas BioPharma, Inc. Common Stock cash flow reinvestment rate. Zenas BioPharma, Inc. Common Stock (ZBIO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $31.85 Million. Explore Zenas BioPharma, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zenas BioPharma, Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)
Zenas BioPharma, Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Zenas BioPharma, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Zenas BioPharma, Inc. Common Stock.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|